[Neostigmine-induced neuromuscular blockade in the corrugator supercilii muscle]

Rev Esp Anestesiol Reanim. 2011 Mar;58(3):147-50. doi: 10.1016/s0034-9356(11)70021-4.
[Article in Spanish]

Abstract

Objective: To investigate whether a single dose of neostigmine, administered when the adductor pollicis muscle presents 2 twitches in train-of-four (TOF) stimulation, can reduce the TOF ratio in the corrugator supercilii muscle.

Patients and methods: We designed a case-control study of patients between 18 and 65 years of age classified ASA 1-2. We used 2 accelerometers--1 for the cubital nerve/thumb adductor muscle and 1 for the facial nerve/corrugator supercilii muscle. Neuromuscular blockade was induced with 0.6 mg x kg(-1) of rocuronium, and 40 microg x kg(-1) of neostigmine was administered at the third twitch in the TOF in the thumb adductor. If the TOF ratio in the corrugator supercilii fell by 10% or more at that time, the patient was classified as a case. We recorded the age, sex, weight, height, body mass index, duration of the procedure, and TOF ratio in the corrugator supercilii muscle when the neostigmine was administered.

Results: Ten cases and 10 controls were enrolled. No significant differences between cases and controls were found in any variables except the mean (SD) TOF ratio in the corrugator supercilii muscle: 70.9% (17.8%) in cases and 35.3% (7.8%) in controls (P < .001).

Conclusions: In our patients, administration of neostigmine after the appearance of the third twitch in TOF stimulation of the thumb adductor was associated with a reduction in the TOF ratio in the corrugator supercilii. The similarity between blockades of the corrugator muscle, the diaphragm, and the larynx is of clinical interest.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Case-Control Studies
  • Cholinesterase Inhibitors / pharmacology*
  • Facial Muscles / drug effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neostigmine / pharmacology*
  • Neuromuscular Blockade*
  • Young Adult

Substances

  • Cholinesterase Inhibitors
  • Neostigmine